Lineage Cell Therapeutics Receives CE Mark Approval for Renevia®
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NYSE: LCTX) | Delayed: 1.02 +0.02 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $ | |||
| Open | $0.99 | 52 Week Low | $ | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $0.98 | EPS | $ | |||
| Volume | 497,710 | |||||
| (NYSE: LCTX) | Delayed: 1.02 +0.02 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $ | |||
| Open | $0.99 | 52 Week Low | $ | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $0.98 | EPS | $ | |||
| Volume | 497,710 | |||||
